These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33258081)

  • 41. Cardiomyocyte Regeneration: A Consensus Statement.
    Eschenhagen T; Bolli R; Braun T; Field LJ; Fleischmann BK; Frisén J; Giacca M; Hare JM; Houser S; Lee RT; Marbán E; Martin JF; Molkentin JD; Murry CE; Riley PR; Ruiz-Lozano P; Sadek HA; Sussman MA; Hill JA
    Circulation; 2017 Aug; 136(7):680-686. PubMed ID: 28684531
    [No Abstract]   [Full Text] [Related]  

  • 42. HiPS-Cardiac Trilineage Cell Generation and Transplantation: a Novel Therapy for Myocardial Infarction.
    Jackson AO; Tang H; Yin K
    J Cardiovasc Transl Res; 2020 Feb; 13(1):110-119. PubMed ID: 31152358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stemming heart failure with cardiac- or reprogrammed-stem cells.
    Tateishi K; Takehara N; Matsubara H; Oh H
    J Cell Mol Med; 2008 Dec; 12(6A):2217-32. PubMed ID: 18754813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disruption of histamine/H
    Zhu X; Ding S; Li H; Zhang Z; Xu L; Wu J; Wang X; Zou Y; Yang X; Ge J
    Stem Cell Res Ther; 2020 Mar; 11(1):27. PubMed ID: 32127042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Highly Conductive 3D Cardiac Patch Fabricated Using Cardiac Myocytes Reprogrammed from Human Adipogenic Mesenchymal Stem Cells.
    Abbasgholizadeh R; Islas JF; Navran S; Potaman VN; Schwartz RJ; Birla RK
    Cardiovasc Eng Technol; 2020 Apr; 11(2):205-218. PubMed ID: 31916039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease.
    Zhang F; Pasumarthi KB
    BioDrugs; 2008; 22(6):361-74. PubMed ID: 18998754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Stem cell-based cardiac regeneration after myocardial infarction].
    Reinsch M; Weinberger F
    Herz; 2018 Mar; 43(2):109-114. PubMed ID: 29243046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The promise of enhancer-associated long noncoding RNAs in cardiac regeneration.
    Ounzain S; Pedrazzini T
    Trends Cardiovasc Med; 2015 Oct; 25(7):592-602. PubMed ID: 25753179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.
    Zhang Z; Yang J; Yan W; Li Y; Shen Z; Asahara T
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induced pluripotent stem cells: developmental biology to regenerative medicine.
    Nelson TJ; Martinez-Fernandez A; Terzic A
    Nat Rev Cardiol; 2010 Dec; 7(12):700-10. PubMed ID: 20956984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac cell therapies: the next generation.
    Choi YH; Saric T; Nasseri B; Hühn S; Van Linthout S; Hetzer R; Tschöpe C; Stamm C
    Cardiovasc Ther; 2011 Feb; 29(1):2-16. PubMed ID: 20946322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Marching towards regenerative cardiac therapy with human pluripotent stem cells.
    Maher KO; Xu C
    Discov Med; 2013 Jun; 15(85):349-56. PubMed ID: 23819949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress and Challenge of Cardiac Regeneration to Treat Heart Failure.
    Isomi M; Sadahiro T; Ieda M
    J Cardiol; 2019 Feb; 73(2):97-101. PubMed ID: 30420106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone-marrow-derived side population cells for myocardial regeneration.
    Sadek HA; Martin CM; Latif SS; Garry MG; Garry DJ
    J Cardiovasc Transl Res; 2009 Jun; 2(2):173-81. PubMed ID: 20559985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions.
    Garbern JC; Escalante GO; Lee RT
    Trends Cardiovasc Med; 2021 Feb; 31(2):85-90. PubMed ID: 31983535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
    Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
    Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.